KUKJEON PHARMACEUTICAL Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 4, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	175,868	172,478	306,192	324,839	537,308
Market Cap Growth	-13.32%	-43.67%	-5.74%	-39.54%	-
Enterprise Value	196,636	178,557	319,290	284,635	-
Last Close Price	3505.00	3515.00	6222.17	6590.26	10900.81
PE Ratio	-	99.34	63.47	36.30	133.06
PS Ratio	1.32	1.26	2.51	3.13	6.30
PB Ratio	1.79	1.77	3.14	3.52	6.46
P/TBV Ratio	1.81	1.80	3.22	3.60	6.50
P/FCF Ratio	1065.41	79.52	-	-	-
P/OCF Ratio	52.65	17.19	-	-	176.63
EV/Sales Ratio	1.48	1.31	2.62	2.75	-
EV/EBITDA Ratio	283.46	32.63	33.11	57.72	-
EV/EBIT Ratio	-	486.92	49.05	81.60	-
EV/FCF Ratio	1191.22	82.32	-	-	-
Debt / Equity Ratio	0.45	0.67	0.81	0.64	0.09
Debt / EBITDA Ratio	52.77	11.94	8.17	12.03	1.09
Debt / FCF Ratio	270.47	30.11	-	-	-
Asset Turnover	0.65	0.62	0.58	0.68	-
Inventory Turnover	5.07	4.22	4.05	4.62	-
Quick Ratio	0.78	0.85	0.94	1.67	2.72
Current Ratio	1.16	1.19	1.24	2.02	3.52
Return on Equity (ROE)	-4.38%	0.55%	4.95%	10.12%	-
Return on Assets (ROA)	-1.33%	0.10%	1.93%	1.44%	-
Return on Capital (ROIC)	-1.71%	0.14%	2.48%	1.80%	-
Return on Capital Employed (ROCE)	-3.80%	0.30%	5.20%	2.80%	7.20%
Earnings Yield	-2.06%	1.01%	1.58%	2.76%	0.75%
FCF Yield	0.09%	1.26%	-14.46%	-9.02%	-1.37%
Dividend Yield	0.29%	0.28%	-	-	-
Payout Ratio	-	28.26%	-	5.48%	-
Buyback Yield / Dilution	-2.21%	-	4.23%	-16.16%	-
Total Shareholder Return	-1.92%	0.28%	4.23%	-16.16%	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.